Display options
Share it on

J Fungi (Basel). 2020 Jun 29;6(3). doi: 10.3390/jof6030096.

CPAnet Registry-An International Chronic Pulmonary Aspergillosis Registry.

Journal of fungi (Basel, Switzerland)

Christian B Laursen, Jesper Rømhild Davidsen, Lander Van Acker, Helmut J F Salzer, Danila Seidel, Oliver A Cornely, Martin Hoenigl, Ana Alastruey-Izquierdo, Christophe Hennequin, Cendrine Godet, Aleksandra Barac, Holger Flick, Oxana Munteanu, Eva Van Braeckel

Affiliations

  1. Pulmonary Aspergillosis Centre Denmark (PACD), Department of Respiratory Medicine, Odense University Hospital, 5000 Odense C, Denmark.
  2. Institute of Clinical Research, University of Southern Denmark, 5000 Odense C, Denmark.
  3. Department of Respiratory Medicine, Ghent University Hospital, B-9000 Ghent, Belgium.
  4. Department of Internal Medicine and Paediatrics, Ghent University, B-9000 Ghent, Belgium.
  5. Department of Pulmonology, Kepler University Hospital, 4021 Linz, Austria.
  6. Department of Internal Medicine, Faculty of Medicine and University of Cologne, Excellence Center for Medical Mycology (ECMM), University of Cologne, 50923 Cologne, Germany.
  7. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50923 Cologne, Germany.
  8. German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, 50923 Cologne, Germany.
  9. Division of Infectious Diseases and Global Health, University of California San Diego, La Jolla, CA 92037 USA.
  10. Section of Infectious Diseases and Tropical Medicine, Medical University of Graz, 8036 Graz, Austria.
  11. Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain.
  12. Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint-Antoine, Service de Parasitologie-Mycologie, F-75012 Paris, France.
  13. Department of Pulmonology, AP-HP, Hôpital Bichat, 75018 Paris, France.
  14. Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, 11000 Belgrade, Serbia.
  15. Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
  16. Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, 8036 Graz, Austria.
  17. Division of Pneumology and Allergology, Department of Internal Medicine, State University of Medicine and Pharmacy "Nicolae Testemitanu", MD-2004 Chisinau, Republic of Moldova.

PMID: 32610566 PMCID: PMC7559693 DOI: 10.3390/jof6030096

Abstract

Chronic pulmonary aspergillosis (CPA) is a chronic fungal infection of the lung associated with high morbidity and mortality. The CPA Research network (CPAnet) registry established in 2018 is an international multicenter collaboration aiming to improve CPA knowledge and patient care. This study's aim was to describe the data collection process and content of CPAnet registry with preliminary clinical data. In the CPAnet registry, clinical data are collected through a web-based questionnaire. Data include CPA phenotype, comorbidities, treatment, outcome, and follow-up from several international centers. An exemplary descriptive analysis was performed on 74 patients, who were registered online before April 2020. CPA patients were predominantly (72%) male, 39% had chronic obstructive pulmonary disease, and 68% had a history of smoking. Chronic cavitary pulmonary aspergillosis was the most common CPA subtype (62%). In 32 patients (52%), voriconazole was the preferred first-line therapy. The multicenter multinational CPAnet registry is a valuable approach to gather comprehensive data on a large study population and reflects real-world clinical practice rather than focusing on specific patient populations in more specialized centers. Additional CPA reference centers are being encouraged to join this promising clinical research collaboration.

Keywords: Aspergillus; CPAnet; antifungals; chronic pulmonary aspergillosis; diagnosis; international collaboration; registry; treatment

References

  1. PLoS One. 2018 Apr 10;13(4):e0193732 - PubMed
  2. Bull World Health Organ. 2011 Dec 1;89(12):864-72 - PubMed
  3. Sci Transl Med. 2012 Dec 19;4(165):165rv13 - PubMed
  4. Clin Infect Dis. 2016 Aug 15;63(4):e1-e60 - PubMed
  5. Emerg Infect Dis. 2018 Aug;24(8): - PubMed
  6. Respiration. 2018;96(2):159-170 - PubMed
  7. Chest. 2016 Jul;150(1):139-47 - PubMed
  8. Eur Respir Rev. 2011 Sep 1;20(121):156-74 - PubMed
  9. Internist (Berl). 2017 Nov;58(11):1150-1162 - PubMed
  10. Clin Infect Dis. 2020 Feb 14;70(5):835-842 - PubMed
  11. Mycoses. 2017 Feb;60(2):136-142 - PubMed
  12. Eur Respir J. 2016 Jan;47(1):45-68 - PubMed
  13. Med Mycol. 2019 Apr 1;57(Supplement_2):S104-S109 - PubMed
  14. Eur Respir J. 2017 Feb 8;49(2): - PubMed
  15. Eur Respir J. 2013 Mar;41(3):621-6 - PubMed
  16. Thorax. 2015 Mar;70(3):270-7 - PubMed
  17. J Antimicrob Chemother. 2018 Feb 1;73(2):280-286 - PubMed
  18. Med Mycol. 2013 May;51(4):361-70 - PubMed

Publication Types